194 related articles for article (PubMed ID: 34845757)
1. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
[TBL] [Abstract][Full Text] [Related]
2. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
3. Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies.
Li H; Zheng J; Luo J; Zeng R; Feng N; Zhu N; Feng Q
PLoS One; 2015; 10(5):e0126610. PubMed ID: 25974033
[TBL] [Abstract][Full Text] [Related]
4. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
Morales DR; Fonkwen L; Nordeng HME
Br J Clin Pharmacol; 2021 Oct; 87(10):3890-3900. PubMed ID: 33783857
[TBL] [Abstract][Full Text] [Related]
5. Teratogen update: Antithyroid medications.
Romeo AN; Običan SG
Birth Defects Res; 2020 Sep; 112(15):1150-1170. PubMed ID: 32738035
[TBL] [Abstract][Full Text] [Related]
6. Safety of antithyroid drugs in pregnancy: update and therapy implications.
Francis T; Francis N; Lazarus JH; Okosieme OE
Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
[No Abstract] [Full Text] [Related]
7. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
[No Abstract] [Full Text] [Related]
8. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.
Liu Y; Li Q; Xu Y; Chen Y; Men Y
PLoS One; 2023; 18(5):e0286097. PubMed ID: 37205692
[TBL] [Abstract][Full Text] [Related]
9. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.
Song R; Lin H; Chen Y; Zhang X; Feng W
PLoS One; 2017; 12(7):e0180108. PubMed ID: 28671971
[TBL] [Abstract][Full Text] [Related]
10. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R; Blichowski M; Koren G
J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
[TBL] [Abstract][Full Text] [Related]
12. Severity of birth defects after propylthiouracil exposure in early pregnancy.
Andersen SL; Olsen J; Wu CS; Laurberg P
Thyroid; 2014 Oct; 24(10):1533-40. PubMed ID: 24963758
[TBL] [Abstract][Full Text] [Related]
13. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
Karras S; Tzotzas T; Kaltsas T; Krassas GE
Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
[TBL] [Abstract][Full Text] [Related]
15. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?
Laurberg P; Andersen SL
Eur J Endocrinol; 2014 Jul; 171(1):R13-20. PubMed ID: 24662319
[TBL] [Abstract][Full Text] [Related]
16. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
[TBL] [Abstract][Full Text] [Related]
18. The efficiency and safety of methimazole and propylthiouracil in hyperthyroidism: A meta-analysis of randomized controlled trials.
Tan S; Chen L; Jin L; Fu X
Medicine (Baltimore); 2021 Jul; 100(30):e26707. PubMed ID: 34397700
[TBL] [Abstract][Full Text] [Related]
19. A Disproportionality Analysis of the Adverse Effect Profiles of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Using the Japanese Adverse Drug Event Report Database.
Arai M; Tsuno T; Konishi H; Nishiyama K; Terauchi Y; Inoue R; Shirakawa J
Thyroid; 2023 Jul; 33(7):804-816. PubMed ID: 37130038
[No Abstract] [Full Text] [Related]
20. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
